Norovirus has no treatment and is highly contagious. It can linger on objects and surfaces for days or even weeks, as it’s resistant to most disinfectants and hand sanitizers, according to the ...

Arrow Therapeutics focused exclusively on novel antiviral drug discovery and development, including several different approaches towards Hepatitis C and Respiratory Syncytial Virus (RSV).

Biopharmaceutical company Ocugen, Inc. (NASDAQ: OCGN) has announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for OCU500, a novel ...

The 30-day risks of hospitalization were 17.5%, 15.9%, and 14.4% for COVID, influenza, and RSV, respectively, during the 2022 ...

At the start of every week, our team talks with local experts to unpack a wide range of nationwide health, safety, and ...

Human metapneumovirus is similar to respiratory syncytial virus (RSV) and primarily affects children 5 years old and younger, Sobolewski said. However, adults, especially older adults, can also ...

The flu, RSV and norovirus have been spreading in the Summit County community this winter, according to the county health department. Rates of flu and RSV, which are both respiratory illnesses ...

The UK's Health Security Agency has been put on "high alert" as cases on a virus originally regarded as a "mystery" illness, which has now been identified as HMPV, have seen an increase over the ...

Cases of flu, COVID and RSV (short for respiratory syncytial virus) tend to start climbing in the fall and peak in the winter months. Currently, emergency room visits for flu and RSV are high and ...

A narrowing of the smallest airways in the lung (bronchioles) causes wheezing. This narrowing results from swelling caused by a virus. The respiratory syncytial virus (RSV) causes most bronchiolitis.

A narrowing of the smallest airways in the lung (bronchioles) causes wheezing. This narrowing results from swelling caused by a virus. The respiratory syncytial virus (RSV) causes most bronchiolitis.

GSK has become the first pharma company to get regulatory approval for a vaccine against respiratory syncytial virus (RSV), setting up what looks set to be a highly lucrative – and likely ...